Sie befinden Sich nicht im Netzwerk der Universität Paderborn. Der Zugriff auf elektronische Ressourcen ist gegebenenfalls nur via VPN oder Shibboleth (DFN-AAI) möglich. mehr Informationen...
Nucleic Acid–Based Functional Nanomaterials as Advanced Cancer Therapeutics
Ist Teil von
Small (Weinheim an der Bergstrasse, Germany), 2019-06, Vol.15 (26), p.e1900172-n/a
Ort / Verlag
Germany: Wiley Subscription Services, Inc
Erscheinungsjahr
2019
Quelle
Wiley Online Library
Beschreibungen/Notizen
Nucleic acid–based functional nanomaterials (NAFN) have been widely used as emerging drug delivery nanocarriers for cancer therapeutics. Considerable works have demonstrated that NAFN can effectively load and protect therapeutic agents, and particularly enable targeting delivery to the tumor site and stimuli‐responsive release. These outstanding performances are due to NAFN's unique properties including inherent biological functions and sequence programmability as well as biocompatibility and biodegradability. In this Review, the recent progress on NAFN as advanced cancer therapeutics is highlighted. Three main cancer therapy approaches are categorized including chemo‐, immuno‐, and gene‐therapy. Examples are presented to show how NAFN are rationally and exquisitely designed to address problems in cancer therapy. The challenges and future development of NAFN are also discussed toward future more practical biomedical applications.
Nucleic acid–based functional nanomaterials (NAFN) have been widely used as emerging drug delivery nanocarriers. In this Review, the recent progress on NAFN as advanced cancer therapeutics is highlighted. Examples are presented to show how NAFN are rationally designed to address the problems in cancer therapy. The challenges and future development of NAFN toward biomedical applications are also discussed.